Background: Inhaled corticosteroids (ICS) markedly reduce bronchial mucosal inflammation ... Patients had mild to moderately severe COPD (FEV 1 25–80% of predicted) and were given 3 months treatment ...

Teva has launched new digital inhaler and drug combination ... blockbuster inhaler Advair (fluticasone+salmeterol). The competition for the product approved in asthma and COPD had been delayed ...

A device costing just pennies, based on an idea by a University of Manchester Professor to help his son use an inhaler, could be a gamechanger for asthma patients. The impressive results are from ...

The Annals of Pharmacotherapy. 2009;43(3):519-527.

Ultrafine particle meter-dose inhalers (MDIs) have not demonstrated superior asthma control or improved safety over older MDIs. All of the inhaled corticosteroids demonstrate efficacy with once ...

Excessive use of reliever inhalers for asthma is linked to a significantly increased risk of dying from the disease, a new study revealed today. Researchers found that over-use of short acting ...

A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers ... or prevention of asthma symptoms ...

Researchers conducted a post hoc analysis of the Step-Up Yellow Zone Inhaled ... persistent asthma who had an initial short-term loss in asthma control. If early signs of asthma control loss occurred, ...

Asthma is a form of bronchial disorder caused by inflammation of the bronchi. It is characterized by spasmodic contraction of airway smooth muscle, difficulty breathing, wheezing and coughing ...